Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?
- PMID: 18957555
- PMCID: PMC2848668
- DOI: 10.1373/clinchem.2008.114686
Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory?
Comment on
-
Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.Clin Chem. 2008 Nov;54(11):1796-804. doi: 10.1373/clinchem.2008.109652. Epub 2008 Sep 18. Clin Chem. 2008. PMID: 18801935 Free PMC article.
References
-
- Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L. The case for early detection. Nat Rev Cancer. 2003;3:243–52. - PubMed
-
- Trusheim MR, Berndt ER, Douglas FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nature Rev. Drug Disc. 2007;6:287–293. - PubMed
-
- Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1:845–67. - PubMed
-
- Anderson NL. The roles of multiple proteomic platforms in a pipeline for new diagnostics. Mol Cell Proteomics. 2005;4:1441–4. - PubMed
-
- Gutman S, Kessler LG. The US Food and Drug Administration perspective on cancer biomarker development. Nat Rev Cancer. 2006;6:565–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
